We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Primary Health Properties plc (PHP) Ordinary Shares 12.5p

Sell:93.45p Buy:93.85p 0 Change: 0.05p (0.05%)
FTSE 250:0.59%
Market closed Prices as at close on 1 April 2025 Prices delayed by at least 15 minutes | Switch to live prices |
Bid situation | Ex-dividend
Sell:93.45p
Buy:93.85p
Change: 0.05p (0.05%)
Market closed Prices as at close on 1 April 2025 Prices delayed by at least 15 minutes | Switch to live prices |
Bid situation | Ex-dividend
Sell:93.45p
Buy:93.85p
Change: 0.05p (0.05%)
Market closed Prices as at close on 1 April 2025 Prices delayed by at least 15 minutes | Switch to live prices |
Bid situation | Ex-dividend
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

HL comment (28 February 2025)

No recommendation - No news or research item is a personal recommendation to deal. All investments can fall as well as rise in value so you could get back less than you invest.

Primary Health Properties (PHP) reported a 2.9% rise in net rental income to £153.6mn and a 2.4% rise in underlying profit to £92.9mn. Growth was largely from rent reviews and asset management projects, offset by higher costs.

Occupancy dipped from 99.3% to 99.1% and the portfolio value was broadly flat at £2.8bn, with values stabilising in the second half. Loan to value on the portfolio worsened from 47.0% to 48.1%.

Dividends over the year totalled 6.9p per share, up 3%. The first interim dividend of the new year was paid on 21 February, totalling 1.775p per share.

The shares were broadly flat in early trading.

Our view

2024 was a decent year for PHP without delivering too much excitement. Rent increases for existing tenants are driving most of its rental growth, but property values are still in a holding pattern – with some signs of improvement in the second half.

PHP’s purpose-built doctor's surgeries have a long track record of delivering results for shareholders and is now in its 29th consecutive year of dividend increases. As a REIT (real estate investment trust), PHP has to pay out the vast majority of profits as a dividend.

PHP has successfully navigated the interest rate rises seen over the past couple of years. Now things have stabilised, its dipping its toe back into the development arena where it usually takes a cautious approach.

A higher cost of capital in today’s market means attractive sites are limited, and PHP is lobbying hard with bodies like the NHS to make projects more viable. There’s progress, but only in areas where the need for new buildings is strongest.

It’s a bit of a balancing act though, as performance over the past couple of years has been driven by rent hikes. Those same elevated costs that limit development opportunities are giving landlords like PHP more bargaining power at the negotiating table.

Looking to the future, we think PHP has several features that underpin long-term dividend-paying potential. The backlog of procedures in the NHS means improving access to primary care is a key component of the UK governments latest plans to improve the NHS. And, with 89% of the group's rent roll funded by the NHS or its Irish equivalent, we view the group's tenants as lower risk.

Ireland is also a key growth driver, with arguably better market dynamics than here in the UK. Leases tend to be longer term, with better yields, and it’s a key area of focus for future growth.

There are some reasons for caution too though. Loan-to-value (LTV) is high by industry standards, and has risen over the past year as property values have struggled to grow. There are also some question marks around growth beyond rent reviews, and with a relatively fresh CEO, there could be changes on the horizon.

We continue to like PHP as a play on a resilient segment of the UK property market and see it as a benefactor of interest rate cuts as and when they come. The valuation isn’t overly demanding, and the prospective dividend yield is attractive – though nothing is guaranteed.

Environmental, social and governance (ESG) risk

Real estate is relatively low risk in terms of ESG. One of the principal drivers of this risk is the capacity to integrate material ESG considerations into decision-making, risk management and public reporting; the most material ESG considerations are environmental, like carbon emissions reduction, energy efficiency and physical climate risk. The rise of hybrid working has also reduced demand for commercial property, making product governance and customer satisfaction a top priority. Other risks to monitor include labour relations, business ethics, and emissions & waste.

According to Sustainalytics, PHP’s overall management of material ESG issues is strong.

Responsibility for overseeing ESG issues is assigned to board level and there is an adequate environmental policy in place. Improvements could be made to ESG related disclosures and executive compensation does not appear to be linked to ESG performance. PHP has targets for increasing investment in sustainable buildings and deadlines to meet those targets, in line with industry best practice.

Primary Health Properties key facts

  • Forward price/book ratio (next 12 months): 0.87

  • Ten year average forward price/book ratio: 1.15

  • Prospective dividend yield (next 12 months): 7.7%

  • Ten year average prospective dividend yield: 5.1%

All ratios are sourced from LSEG Datastream, based on previous day’s closing values. Please remember yields are variable and not a reliable indicator of future income. Keep in mind key figures shouldn’t be looked at on their own – it’s important to understand the big picture.

This article is original Hargreaves Lansdown content, published by Hargreaves Lansdown. It was correct as at the date of publication, and our views may have changed since then. Unless otherwise stated estimates, including prospective yields, are a consensus of analyst forecasts provided by Refinitiv. These estimates are not a reliable indicator of future performance. Yields are variable and not guaranteed. Investments rise and fall in value so investors could make a loss.

This article is not advice or a recommendation to buy, sell or hold any investment. No view is given on the present or future value or price of any investment, and investors should form their own view on any proposed investment. This article has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is considered a marketing communication. Non-independent research is not subject to FCA rules prohibiting dealing ahead of research, however HL has put controls in place (including dealing restrictions, physical and information barriers) to manage potential conflicts of interest presented by such dealing. Please see our full non-independent research disclosure for more information.


Previous Primary Health Properties plc updates

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.